JPWO2022165133A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022165133A5 JPWO2022165133A5 JP2023544092A JP2023544092A JPWO2022165133A5 JP WO2022165133 A5 JPWO2022165133 A5 JP WO2022165133A5 JP 2023544092 A JP2023544092 A JP 2023544092A JP 2023544092 A JP2023544092 A JP 2023544092A JP WO2022165133 A5 JPWO2022165133 A5 JP WO2022165133A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- cell
- cells
- starting
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142730P | 2021-01-28 | 2021-01-28 | |
| US63/142,730 | 2021-01-28 | ||
| US202263302225P | 2022-01-24 | 2022-01-24 | |
| US63/302,225 | 2022-01-24 | ||
| PCT/US2022/014247 WO2022165133A1 (en) | 2021-01-28 | 2022-01-28 | Methods for transducing immune cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024508223A JP2024508223A (ja) | 2024-02-26 |
| JP2024508223A5 JP2024508223A5 (https=) | 2025-02-04 |
| JPWO2022165133A5 true JPWO2022165133A5 (https=) | 2025-02-04 |
Family
ID=80685286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544092A Pending JP2024508223A (ja) | 2021-01-28 | 2022-01-28 | 免疫細胞を形質導入する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12365873B2 (https=) |
| EP (1) | EP4284937A1 (https=) |
| JP (1) | JP2024508223A (https=) |
| KR (1) | KR20230135593A (https=) |
| AU (1) | AU2022212090A1 (https=) |
| CA (1) | CA3204357A1 (https=) |
| IL (1) | IL303847A (https=) |
| MX (1) | MX2023008662A (https=) |
| TW (1) | TW202246517A (https=) |
| WO (1) | WO2022165133A1 (https=) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846534A (en) | 1988-02-12 | 1998-12-08 | British Technology Group Limited | Antibodies to the antigen campath-1 |
| US6319494B1 (en) | 1990-12-14 | 2001-11-20 | Cell Genesys, Inc. | Chimeric chains for receptor-associated signal transduction pathways |
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| CA2406864A1 (en) | 2000-02-24 | 2001-08-30 | Life Technologies Corporation | Simultaneous stimulation and concentration of cells |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| EP3659435A1 (en) * | 2009-07-15 | 2020-06-03 | Calimmune, Inc. | Dual vector for inhibition of human immunodeficiency virus |
| WO2011146862A1 (en) | 2010-05-21 | 2011-11-24 | Bellicum Pharmaceuticals, Inc. | Methods for inducing selective apoptosis |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CN110200997A (zh) | 2011-03-23 | 2019-09-06 | 弗雷德哈钦森癌症研究中心 | 用于细胞免疫治疗的方法和组合物 |
| CN103316356B (zh) | 2012-03-22 | 2016-08-17 | 北京三诺佳邑生物技术有限责任公司 | 一种重组慢病毒载体制剂 |
| GB201206559D0 (en) | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| FR3010720B1 (fr) | 2013-09-16 | 2017-08-11 | Genethon | Procede de production de virus enveloppes |
| FR3014901B1 (fr) | 2013-12-17 | 2017-06-09 | Genethon | Procede de purification de virus ou vecteurs viraux enveloppes |
| JP2017505819A (ja) | 2014-02-04 | 2017-02-23 | カイト ファーマ インコーポレイテッドＫｉｔｅ Ｐｈａｒｍａ， Ｉｎｃ | Ｂ細胞悪性腫瘍及び他のがんの治療に有用な自己ｔ細胞を産生する方法、並びにその組成物 |
| ES2869972T3 (es) | 2015-01-26 | 2021-10-26 | Cellectis | Sistemas de receptores de antígenos quiméricos dirigidos por mAb para clasificar/agotar células inmunitarias genomanipuladas |
| EP3364969A4 (en) * | 2015-10-20 | 2019-07-10 | Kite Pharma, Inc. | METHOD FOR THE PRODUCTION OF T CELLS FOR T CELL THERAPY |
| IL261713B2 (en) | 2016-03-19 | 2023-09-01 | F1 Oncology Inc | Methods and preparations for the transfer of lymphocytes and their regulated expansion |
| MY210545A (en) * | 2016-04-01 | 2025-09-30 | Kite Pharma Inc | Chimeric receptors to flt3 and methods of use thereof |
| SG10202107808SA (en) | 2017-01-18 | 2021-08-30 | F1 Oncology Inc | Chimeric antigen receptors against axl or ror2 and methods of use thereof |
| WO2018136566A1 (en) | 2017-01-18 | 2018-07-26 | F1 Oncology, Inc. | Methods of transducing and expanding immune cells and uses thereof |
| AU2018226884B2 (en) | 2017-03-03 | 2024-11-07 | Exuma Biotech, Corp. | Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof |
-
2022
- 2022-01-28 AU AU2022212090A patent/AU2022212090A1/en active Pending
- 2022-01-28 KR KR1020237025863A patent/KR20230135593A/ko active Pending
- 2022-01-28 MX MX2023008662A patent/MX2023008662A/es unknown
- 2022-01-28 CA CA3204357A patent/CA3204357A1/en active Pending
- 2022-01-28 WO PCT/US2022/014247 patent/WO2022165133A1/en not_active Ceased
- 2022-01-28 IL IL303847A patent/IL303847A/en unknown
- 2022-01-28 US US17/587,138 patent/US12365873B2/en active Active
- 2022-01-28 EP EP22709435.6A patent/EP4284937A1/en active Pending
- 2022-01-28 TW TW111103878A patent/TW202246517A/zh unknown
- 2022-01-28 JP JP2023544092A patent/JP2024508223A/ja active Pending
-
2025
- 2025-06-17 US US19/241,275 patent/US20260009000A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6970106B2 (ja) | Ｖｃｎエンハンサー組成物およびその使用方法 | |
| US5591625A (en) | Transduced mesenchymal stem cells | |
| JP6691048B2 (ja) | 方法 | |
| CN1531596A (zh) | 用病毒载体稳定转导细胞的方法 | |
| US9670459B2 (en) | Production method for cell populations | |
| AU2025204595A1 (en) | Platform for generating safe cell therapeutics | |
| JP7228523B2 (ja) | ヘモグロビン異常症を治療するためのベクターおよび組成物 | |
| EP3413896B1 (en) | Vcn enhancer compositions and methods of using the same | |
| JPWO2021222287A5 (https=) | ||
| JP7080184B2 (ja) | 遺伝子送達の増強方法 | |
| CN113660942A (zh) | 嵌合细胞因子受体 | |
| US11261441B2 (en) | Vectors and compositions for treating hemoglobinopathies | |
| JP2026027332A (ja) | 栄養障害型表皮水疱症の治療薬 | |
| JP5911810B2 (ja) | 制御性ｔ細胞の製造方法 | |
| JPWO2022165133A5 (https=) | ||
| CN102046780A (zh) | 转染的细胞的生产方法 | |
| WO2008136656A1 (en) | Improved methods and means for lentiviral gene delivery | |
| JPWO2020264019A5 (https=) | ||
| JP2022536935A (ja) | 細胞性免疫及び体液性免疫を誘導するための同種異系ｔ細胞ベースのｈｉｖワクチン | |
| Ansorge et al. | Towards continuous bioprocessing of lentiviral vectors | |
| EP1551970A2 (en) | Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor | |
| JP2005514071A (ja) | 内皮細胞との前培養による遺伝子導入効率の上昇 | |
| KR20240101969A (ko) | 인테그린 발현 조절을 통한 중간엽 줄기세포의 면역조절 활성 증진 방법 | |
| WO2023140349A1 (ja) | 細胞シート | |
| Restrepo et al. | Transduction of CD34+ PBSC Mobilized in Cancer Patients Using a Novel Fr-MuLV Retrovirus Vector Derived from FB29 Highly Titrating Strain |